{"id":"W2587349694","doi":"10.18192/uojm.v7i1.1563","title":"Triple Negative Breast Cancer: A review of common therapeutic Targets and Current Treatment options.","year":2017,"lang":"en","type":"review","venue":"University of Ottawa Journal of Medicine","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Triple-negative breast cancer; Carboplatin; Breast cancer; Oncology; Internal medicine; Cancer; Chemotherapy; Clinical trial; Bevacizumab; Adjuvant; Cancer research; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005534524,0.0006614661,0.001096553,0.002127013,0.0002988615,0.0009080297,0.0009522929,0.0008135379,0.003909188],"category_scores_gemma":[0.0006838077,0.0002551227,0.0005836589,0.002154397,0.0003666425,0.001323598,0.0005823072,0.00156873,0.001600993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006490354,"about_ca_system_score_gemma":0.0009422334,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001194924,"about_ca_topic_score_gemma":0.002910635,"domain_scores_codex":[0.999809,0.00003091093,0.00003480318,0.00003254648,0.00007203296,0.00002075873],"domain_scores_gemma":[0.9997059,0.0001124182,0.00005460472,0.000008347123,0.00007769131,0.00004113048],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001406613,0.0001003056,0.0003976699,0.01545771,0.0000843964,0.0003414233,0.00007517432,0.0003634252,0.001396505,0.002188967,0.06141347,0.9180403],"study_design_scores_gemma":[0.0000239116,0.000197776,0.001180224,0.004707667,0.0001528759,0.002337553,0.00010026,0.0001435216,0.0003023865,0.001576653,0.9892522,0.00002504113],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001773907,0.9982236,0.0001111884,0.0004985689,0.0001737103,0.000006564542,0.00004006115,0.00001080178,0.0007580559],"genre_scores_gemma":[0.0007995462,0.9977102,0.0002400271,0.0003923175,0.0002477697,0.00001233814,0.0001056973,0.000002145626,0.0004898536],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003909188,"threshold_uncertainty_score":0.01307756,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07844334886115388,"score_gpt":0.3885889983004034,"score_spread":0.3101456494392495,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}